ArticleBMC cancer2013

Sensitization of human cancer cells to gemcitabine by the Chk1 inhibitor MK-8776: cell cycle perturbation and impact of administration schedule in vitro and in vivo.

Ryan Montano et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.